z-logo
Premium
Can serum HBV‐DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?
Author(s) -
Alberti Alfredo
Publication year - 2003
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1053/jhep.2003.50280
Subject(s) - chronic hepatitis , citation , medicine , end point , library science , family medicine , virology , computer science , virus , real time computing

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom